Amarin Corporation PLC
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. … Read more
Amarin Corporation PLC - Asset Resilience Ratio
Amarin Corporation PLC (AMRN) has an Asset Resilience Ratio of 25.04% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Amarin Corporation PLC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Amarin Corporation PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $167.93 Million | 25.04% |
| Total Liquid Assets | $167.93 Million | 25.04% |
Asset Resilience Insights
- Very High Liquidity: Amarin Corporation PLC maintains exceptional liquid asset reserves at 25.04% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Amarin Corporation PLC Industry Peers by Asset Resilience Ratio
Compare Amarin Corporation PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
Drug Manufacturers - General | 5.75% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367 |
Drug Manufacturers - General | 32.14% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
Drug Manufacturers - General | 0.00% |
|
PharmGen Science Inc
KO:004720 |
Drug Manufacturers - General | 0.16% |
Annual Asset Resilience Ratio for Amarin Corporation PLC (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Amarin Corporation PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 25.04% | $167.93 Million | $670.77 Million | -0.23pp |
| 2024-12-31 | 25.27% | $173.18 Million | $685.35 Million | +10.67pp |
| 2023-12-31 | 14.60% | $121.41 Million | $831.68 Million | +4.25pp |
| 2022-12-31 | 10.35% | $91.69 Million | $886.18 Million | -11.62pp |
| 2021-12-31 | 21.97% | $234.67 Million | $1.07 Billion | -10.53pp |
| 2020-12-31 | 32.50% | $313.97 Million | $966.02 Million | +32.13pp |
| 2017-12-31 | 0.37% | $600.00K | $161.60 Million | +0.01pp |
| 2016-12-31 | 0.36% | $600.00K | $167.00 Million | +0.01pp |
| 2015-12-31 | 0.35% | $600.00K | $173.46 Million | 0.00pp |
| 2014-12-31 | 0.35% | $600.00K | $171.11 Million | -0.05pp |
| 2013-12-31 | 0.40% | $1.00 Million | $252.48 Million | -7.79pp |
| 2008-12-31 | 8.18% | $3.00 Million | $36.66 Million | +8.11pp |
| 2001-12-31 | 0.07% | $64.00K | $90.99 Million | -30.90pp |
| 2000-12-31 | 30.97% | $15.05 Million | $48.60 Million | -- |